Christopher Chapple led the peer-review process as the Associate Editor responsible for the paper.
Long-term outcomes of autologous pubovaginal fascia slings: Is there a difference between primary and secondary slings?
Version of Record online: 16 OCT 2013
© 2013 Wiley Periodicals, Inc.
Neurourology and Urodynamics
Volume 34, Issue 1, pages 18–23, January 2015
How to Cite
Lee, D., Murray, S., Bacsu, C. D. and Zimmern, P. E. (2015), Long-term outcomes of autologous pubovaginal fascia slings: Is there a difference between primary and secondary slings?. Neurourol. Urodyn., 34: 18–23. doi: 10.1002/nau.22502
Conflict of interest: none.
- Issue online: 12 DEC 2014
- Version of Record online: 16 OCT 2013
- Manuscript Accepted: 17 SEP 2013
- Manuscript Received: 2 JUL 2013
- functional outcomes;
- long term;
- pubovaginal slings
To report our long-term pubovaginal slings (PVS) outcomes between primary (PVS1) and secondary (PVS2) autologous fascia PVS, with the hypothesis that outcomes in PVS1 will be better than in PVS2.
Materials and Methods
IRB approved retrospective study of women undergoing PVS between 1996 and 2011 with minimum 6 months follow-up. Data reviewed included demographics, questionnaires that is, UDI-6, IIQ-7, QOL, prior anti-incontinence procedure, associated repairs, urodynamic findings and repeat procedures. Primary outcome and surgical success defined by: (1) QOL ≤ 3, (2) UDI question 3 on SUI ≤ 1, and (3) no SUI re-treatment/operation. Secondary outcomes included all other patient reported outcome measures (PROM).
Of 110 patients, 84 had follow-up. Mean age was 61 years (38–88) and median follow-up was 89 months (7–189). Demographic findings and type of fascia used were similar between the two groups. Mean postoperative scores were not statistically significant for total UDI-6 score (P = 0.62), IIQ-7 (P = 0.30) and QOL (P = 0.35) between groups, but was statistically significant compared to baseline (P = 0.001) as expected. Twelve patients, 3 in PVS1 and 9 in PVS2 underwent subsequent procedures. Surgical success rate was 76% in PVS1 and 52% in PVS2 for those with completed questionnaires. Overall, 78% (28) in PVS1 and 69% (33) in PVS 2 required no further surgical intervention at last follow-up.
At long-term follow-up of average 7.4 years, primary and secondary PVS patients had comparable favourable functional outcomes with low morbidity. However, secondary PVS patients had lower success rates as per our definition with higher rate of additional procedures. Neurourol. Urodynam. 34:18–23, 2015. © 2013 Wiley Periodicals, Inc.